EBF2 and gastric cancer: The high level of EBF1 (HR = 1.62, 95% CI = 1.14–2.29, P=0.014, Figure 2C) related to the poor prognosis of GC patients, as well as EBF2 (HR = 1.68, 95% CI = 1.21–2.33, P=0.002, Figure 2D), EBF3 (HR = 1.64, 95% CI = 1.17–2.31, P=0.009, Figure 2E), and EBF4 (HR = 1.68, 95% CI = 1.21–2.34, P=0.003, Figure 2F).